DrugDashboards

omega-3 fish oil

omega-3 fish oil · ICOSAPENT 300 mg/1; FISH OIL 1000 mg/1; DOCONEXENT 200 mg/1 · Capsule · Prodose, Inc

NDC 68210-5069-01 · 100 CAPSULE in 1 BOTTLE · DRUG FOR FURTHER PROCESSING · View full market →

Bulk ingredient — not a finished product

This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.

Medicare Part D

This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Regulatory

Application
TE code
Approval date
Patents / exclusivity

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of omega-3 fish oil (Capsule)

LabelerStrengthFirst seenLast seen
Prodose, IncICOSAPENT 300 mg/1; FISH OIL 1000 mg/1; DOCONEXENT 200 mg/1Aug 20, 2026Sep 3, 2026
Prodose, IncICOSAPENT 200 mg/1; FISH OIL 1000 mg/1; DOCONEXENT 300 mg/1Jul 22, 2026Aug 19, 2026
Prodose, IncDOCONEXENT 200 mg/1; FISH OIL 1000 mg/1; ICOSAPENT 300 mg/1Jul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "omega-3 fish oil — NDC 68210-5069-01," retrieved September 3, 2026, https://drugdashboards.com/drug/68210506901.

Free to cite with attribution — see how the data is put together.